FDA Approved: AMPYRA — Original Application (Merz Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved AMPYRA (dalfampridine) through its Original Application submitted by Merz Pharmaceuticals for improving walking in adults with multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Ampyra (4-aminopyridine)

Snippet

ORIG AP for AMPYRA (DALFAMPRIDINE)